Phenotypic Severity Determines Overall Pregnancy Outcome and Survival in Fetuses With Turner Syndrome: Insights From a Large Multicenter Cohort
In brief
Major abnormalities predict nearly fivefold higher intrauterine death risk in fetal Turner syndrome
In this 726-pregnancy cohort, severe abnormalities on prenatal imaging were associated with nearly fivefold higher intrauterine death risk. Of pregnancies that continued, 35.6% ended in live birth and 64.4% in fetal death; mosaic and structural karyotypes had lower death risk than 45,X. Because outcomes also reflect elective termination decisions, survival estimates need careful interpretation.
- Journal
- Prenatal diagnosis (Q1)
- Published
- 18 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Ivonne Bedei, Johanna Bruder, Anita C Windhorst, Roland Axt-Fliedner, Anne Skakkebæk, Claus H Gravholt
- PMID
- 43051889
- DOI
- 10.1002/pd.70302
Why clinicians should know about it
- Picked for Genetics (clinical) (top studies of the week, 22 November 2026): Prenatal Turner syndrome cohort informs counseling about survival
Abstract
OBJECTIVE: To evaluate survival in fetuses with prenatally diagnosed Turner syndrome (TS) according to karyotype and phenotypic severity, and to estimate minimal survival (MS) proportions across cytogenetic subgroups. METHODS: Retrospective multicentre cohort study including fetuses with prenatal TS diagnosed between 2000 and 2024. Karyotypes were classified as 45,X; mosaic; or structural X-chromosome anomalies. Phenotypic severity was defined by major structural abnormalities on prenatal imaging. Survival analyses and Cox proportional hazard models were applied. MS was calculated as the proportion of Live births (LB) relative to elective terminations (ET) and Spontaneous intrauterine deaths (SID) within each karyotype group. RESULTS: Among 726 pregnancies, 451 (62.1%) were ET, 275 (37.9%) continued; of these, 98 (35.6%) resulted in LB and 177 (64.4%) in SID. Severe phenotypes were present in 92.4% of terminations, 81.0% of SIDs and 33.0% of LB. Mosaic and structural karyotypes showed a lower risk of intrauterine death than 45,X (HR 0.28 and 0.32), while severe phenotype strongly predicted mortality (HR 4.82). Most SIDs occurred before 30 weeks' gestation (median 21 weeks). MS was 9.6% for 45,X, 50.0% for mosaic and 36.8% for structural variants. CONCLUSION: Survival in prenatally diagnosed TS is higher than historically reported. Phenotypic severity is the principal determinant of outcome.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.